Nightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...

AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...

In a research trial published Wednesday in the scientific journal Nature, Drew was the only one of 11 patients with DIPG and a related cancer to show such a phenomenal success. But the fact that it's ...

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Kenai Therapeutics today announced the formation of a Patient Advisory Board comprised of leading experts and advocates in ...

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseActive ...

In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause ...